There is "insufficient" evidence available to support the introduction a Meningitis B immunisation, Government-appointed experts have said.
The Joint Committee on Vaccination and Immunisation (JCVI) said the efficacy of the Bexsero vaccine "has not been established" and it is "high unlikely" to be cost-effective.
The vaccine was licensed by the European Medicines Agency at the start of the year.
More top news
UK defence secretary says so-called Islamic State group will only be defeated by force.
Sheriff's deputies were called to the scene in LA County after residents reported hearing muffled crying.
Further one in eight expect to be aged between 71 and 80 years when they finally stop work, according to survey.